PHI with Hemangioma
How does this condition affect your private health insurance?
A hemangioma is a common type of benign (non-cancerous) vascular tumor, typically appearing during infancy. It results from an abnormal proliferation of blood vessels. Often presenting as a red or purplish raised lesion on the skin, they can also occur internally. Infantile hemangiomas usually grow rapidly during the first few months of life (proliferative phase) before slowly shrinking and fading over several years (involution phase). While most resolve without significant issues, some can cause complications like ulceration, bleeding, or, if located near vital organs (e.g., eyes, airway), functional impairment. Treatment is usually reserved for complicated cases.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months (proliferative phase of growth)
Duration of Illness (Lifetime)
Typically resolves over several years (involution phase), often by age 5-10.
Cost of Treatment (Initial)
Variable, from minimal (observation) to moderate (topical or oral medication) or high (laser, surgery) if intervention is needed.
Cost of Treatment (Lifetime)
Variable, often minimal as most resolve spontaneously; can be moderate to high if ongoing treatment or management of complications is required over years.
Mortality Rate
Extremely low, nearly negligible for typical hemangiomas; higher in very rare cases of severe visceral involvement or life-threatening complications.
Risk of Secondary Damages
Moderate (e.g., ulceration, scarring, infection); higher if located near vital structures affecting function (e.g., vision, breathing, feeding).
Probability of Full Recovery
High, with spontaneous regression being common; most involute completely or leave minimal skin changes.
Underlying Disease Risk
Low for typical infantile hemangiomas; higher in specific syndromic associations (e.g., PHACES syndrome, LUMBAR syndrome), which are rare.